[V2.0 -- NEW SECTION]
[GRADE A1 -- EFTA01416771, EFTA01369678, EFTA01460272, EFTA01265973]
Deep mining across the EFTA corpus reveals Kahn held formal positions in 15+ entities:
| Entity | Kahn's Role | Source |
|---|---|---|
| HBRK Associates Inc. | Principal / Owner | Multiple |
| Southern Trust Company Inc. | Agent / CFO | EFTA01265973 |
| Southern Financial LLC | Signatory / "Treasurer" | EFTA01344265, EFTA02637769 |
| Southern Country International | Officer | EFTA00128637 |
| Neptune LLC | Manager | EFTA01416771 |
| Butterfly Trust | Trustee and Beneficiary | EFTA01369678, EFTA01416771 |
| [Entity -- EFTA01460272] | President | EFTA01460272 |
| Coatue Enterprises LLC | Registered Agent (via HBRK) | EFTA01265973 |
| Gratitude America | Account opener / signatory | EFTA01476934 |
| J Epstein VI Foundation | Wire coordinator | EFTA02349071 |
| Truth Robot LLC | Designated Treasurer | EFTA02637769 |
| Valar Ventures (LP accounts) | Capital call executor | Multiple |
| Epstein Estate | Co-Executor | DOJ-OGR-00015259 |
Kahn served as both Trustee and Beneficiary of the Butterfly Trust (EFTA01369678, EFTA01416771). In the same trust, other beneficiaries include Celina Dubin (DOB 3/31/1995), Karyna Shuliak, and Darren Indyke. As co-executor of the estate that funds the trust, Kahn sits on all three sides of the fiduciary relationship -- a structural conflict that would be unusual in legitimate trust management.
Kahn served as financial contact for Epstein's DNA/genomics program:
Documents show Kahn forwarding news articles to Epstein on politically and legally sensitive topics, functioning as an information relay beyond pure financial management. Examples include Jeff Sessions articles, Leon Black media coverage, and the witness tampering NYT article (EFTA01421364) sent to the DB banker.
WHAT THIS SHOWS AND DOES NOT SHOW: The entity map establishes Kahn as a control person across the full spectrum of Epstein-related entities -- financial (STC, SF), offshore (SCI), trust (Butterfly), charity (Gratitude America), investment (Valar, Carbyne), and shell (Neptune, Truth Robot). His simultaneous Trustee/Beneficiary status in Butterfly Trust creates a documented fiduciary conflict. The DNA database management payment and genome sequencing coordination position Kahn as the financial infrastructure for Epstein's genetic data collection program. The documents do NOT establish that Kahn understood the purpose of the DNA database or genome sequencing beyond financial management.